Genomic duplex DNA minor groove at CpG-rich triplets with central guanine

The genomic duplex DNA minor groove at CpG-rich triplets with a central guanine is a specific structural motif within the DNA double helix that serves as a high-affinity binding site for certain antitumor antibiotics. This site is characterized by a high concentration of cytosine and guanine bases, which create a unique electrostatic and steric environment in the minor groove (Sastry & Patel, 1993, Biochemistry). Drugs such as Mithramycin (Plicamycin) bind to these sequences in a magnesium-dependent manner, occupying the groove and preventing the association of GC-binding transcription factors like Sp1 (Waring, 1970, J. Mol. Biol.). This inhibition leads to the downregulation of genes involved in cell proliferation and survival, making it a target of interest in oncology, particularly for Ewing sarcoma where it disrupts the EWS-FLI1 oncogenic driver (Grohar et al., 2011, JNCI). However, because these GC-rich motifs are prevalent throughout the genome, drugs targeting this site often exhibit significant off-target effects and systemic toxicity, including liver and kidney damage (Previdi et al., 2010, Eur. J. Cancer).

Other names

GC-rich DNA minor grooveCpG-rich DNA minor grooveMithramycin binding siteGC-box DNA motif5-XGX-3 minor groove site

Drugs target this site by binding within the minor groove of GC-rich DNA sequences, specifically triplets with a central guanine (e.g., 5-GGC-3 or 5-CGC-3), in a magnesium-dependent manner. This occupancy sterically hinders the binding of GC-specific transcription factors, such as Sp1, to their cognate promoter regions, thereby inhibiting the transcription of downstream genes (Blume et al., 1991, J. Clin. Invest.; Sastry & Patel, 1993, Biochemistry).